Patients with advanced skin care cancer will be fast-tracked into trials of the needle-free injection that boosts the immune system as part of NHSE's Cancer Vaccine Launch Pad (CVLP).

CVLP is a world-first programme to fast-track eligible patients to studies developing vaccines against different cancers at their nearest participating hospital.

NHS national cancer director Professor Peter Johnson said: ‘Skin cancer can have a devastating impact and we know that cancer vaccines have the potential to revolutionise cancer care for patients in this country and across the world – and to save more lives.

‘It's incredibly exciting that the NHS is expanding its world-leading programme so more patients with different types of cancer could benefit from the development of new vaccines that could stop their cancer coming back.

‘We want to ensure as many eligible NHS patients as possible have access to these vital trials, which is why we are working with a range of industry partners as more studies get up and running to ensure patients are fast-tracked to a vaccine that could transform lives.'